Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein, Inc. reports developments across its health care distribution, practice solutions, and dental technology businesses. The company serves office-based dental and medical practitioners, dental laboratories, government and institutional health care clinics, and other alternate care sites through business, clinical, technology, and supply chain solutions.
Recurring news themes include earnings releases, financial guidance, investor conference participation, board and executive governance updates, and product announcements from Henry Schein One. Recent technology coverage centers on Dentrix Ascend, a cloud-based dental platform that integrates practice management, clinical workflows, imaging, revenue cycle management, analytics, patient experience tools, and AI-enabled workflow capabilities.
Henry Schein (NASDAQ: HSIC) announced a donation of $200,000 in health care products to Howard University College of Dentistry and Meharry Medical College School of Dentistry. This donation aims to support free oral health care for underserved communities through student outreach programs. During his commencement address, Stanley M. Bergman, CEO, emphasized the importance of health equity. Each graduate of Howard will also receive $1,000 in health care products for charitable care. The company will extend its partnership with Howard University for another four years.
Henry Schein, Inc. (Nasdaq: HSIC), a leading health care solutions provider, will present at the UBS Global Healthcare Conference on May 24, 2022, at 2:00 p.m. Eastern time. The presentation will be available via live webcast on their website, with a replay accessible afterward.
Henry Schein serves over 1 million customers globally with a wide range of solutions, achieving $12.4 billion in sales in 2021. The company operates a centralized distribution network and provides more than 120,000 branded products.
Henry Schein reported record first-quarter 2022 net sales of $3.2 billion, an 8.7% increase from Q1 2021. The GAAP diluted EPS rose to $1.30, up from $1.16 the previous year. The company affirms its full-year 2022 GAAP diluted EPS guidance of $4.75 to $4.91, projecting growth of 7% to 10% over 2021. Growth was driven by strong sales in both the dental and medical segments, particularly in equipment and technology sales. However, sales of COVID-19 related products are expected to decline, impacting overall sales guidance.
Henry Schein (NASDAQ: HSIC) supports the Carry The Load Memorial May campaign, honoring military, veterans, first responders, and their families. The initiative, running from April 28, 2022, involves events such as the Dallas Memorial March and other rallies across the U.S. Team Schein Members will participate in walks, fundraise, and attend educational events. This partnership aligns with Henry Schein's commitment to veterans' health and accessibility to dental care, showcasing its corporate social responsibility through meaningful community engagement.
Summary not available.
Henry Schein, a leading provider of health care solutions, will release its Q1 2022 financial results on May 3, 2022, before market opening. The live webcast of the earnings call starts at 10:00 a.m. Eastern time on the same day. Key speakers include Stanley M. Bergman and Ronald N. South, the new CFO. Investors can access the call via www.henryschein.com/IRwebcasts. Henry Schein, headquartered in Melville, N.Y., operates in 32 countries and reported sales of $12.4 billion in 2021.
Henry Schein, the leading provider of healthcare solutions, announced the retirement of Gerald A. Benjamin as Chief Administrative Officer, effective July 1, 2022. He has served the company for 34 years and will remain an adviser post-retirement. Michael S. Ettinger will be promoted to Chief Operating Officer on the same date, taking on expanded responsibilities. His extensive experience at Henry Schein since 1994 positions him well for this leadership transition. This change marks the implementation of a long-planned succession strategy within the company.
Henry Schein, the leading provider of health care solutions, has promoted Jennifer Ferrero to Vice President, Senior Counsel and Corporate Secretary, effective July 1, 2022. Ms. Ferrero has been with the company since 2004, previously serving as Vice President, Senior Counsel, Corporate & Deputy Secretary. In her new role, she will oversee corporate governance and board activities. CEO Stanley M. Bergman commended her for her leadership and expertise, particularly in Environmental, Social & Governance (ESG) matters.
Henry Schein (Nasdaq: HSIC), a leading provider of health care solutions, announced its participation in the Piper Sandler Dental Investor Day on March 29, 2022, at 9:00 a.m. Eastern time. Investors can access the live webcast on the company's website, with a replay available afterward. Headquartered in Melville, N.Y., Henry Schein serves over 1 million customers globally, reporting sales of $12.4 billion in 2021. The company is a member of the S&P 500 and has a broad product portfolio and a network of over 21,600 employees.
Henry Schein has been recognized as one of the 2022 World’s Most Ethical Companies by Ethisphere for the 11th consecutive year, being the only honoree in the Healthcare Products industry. The recognition highlights the company’s commitment to ethical practices, aligning with its philosophy of ‘doing good’ to achieve business success. The Ethics Index shows that honorees outperformed a comparable index by 24.6 percentage points over five years, emphasizing the financial benefits of ethical governance.